San Diego, CA, United States of America

Tso-sheng Chou


Average Co-Inventor Count = 13.0

ph-index = 1

Forward Citations = 18(Granted Patents)


Company Filing History:


Years Active: 2002

Loading Chart...
1 patent (USPTO):Explore Patents

Title: **Innovative Contributions of Tso-sheng Chou**

Introduction

Tso-sheng Chou, based in San Diego, California, is a distinguished inventor known for his impactful contributions to the field of pharmaceuticals. His innovative work primarily focuses on developing non-peptide antagonists of the GLP-1 receptor, which holds significant implications for medicinal applications.

Latest Patents

Chou’s notable patent, titled "Non-peptide antagonists of GLP-1 receptor and methods of use," showcases his creativity in designing non-peptide compounds with a unique 9H-b-carboline central motif. These compounds demonstrate beneficial physical, chemical, and biological properties, effectively inhibiting the binding of the intestinal hormone glucagon-like peptide 1 (GLP-1) to its receptor. This invention not only describes methods to hinder GLP-1 peptide binding but also outlines ways to prevent receptor activation. Furthermore, it includes intermediate compounds that can be utilized to create these non-peptide GLP-1 receptor antagonists.

Career Highlights

Chou is currently associated with Agouron Pharmaceuticals, Inc., where he utilizes his expertise in pharmaceutical research and development. His innovative spirit and commitment to advancing medical science have played an essential role in the ongoing improvements in therapeutic strategies targeting metabolic disorders.

Collaborations

Throughout his career, Tso-sheng Chou has collaborated with esteemed colleagues, including Larry Kenneth Truesdale and Richard A. Bychowski. These collaborations have fostered a rich exchange of ideas, further enhancing the quality and scope of their research endeavors.

Conclusion

Tso-sheng Chou's contributions to the field of pharmacology through his inventive patent illustrate the importance of innovation in developing new therapeutic agents. His work not only advances scientific knowledge but also has the potential to improve health outcomes for individuals affected by conditions related to GLP-1 receptor activity. As the landscape of medicine continues to evolve, Chou's inventions exemplify the critical role inventors play in driving progress and enhancing lives.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…